Bellecapital International Ltd. Amgen Inc Transaction History

Bellecapital International Ltd.

$484 Million
Q3 2024

A detailed history of Bellecapital International Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Bellecapital International Ltd. holds 2,239 shares of AMGN stock, worth $592,193. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,239

Previous 3,130 28.47%

Holding current value

$592,193

Previous $977,000 26.2%

% of portfolio

0.15%

Previous 0.22%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $275,657 - $300,605	-891 Reduced 28.47%	2,239 $721,000
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $23,929 - $28,885	-89 Reduced 2.76%	3,130 $889,000
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $30,172 - $34,038	-118 Reduced 3.54%	3,219 $927,000
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $1,311 - $1,628	6 Added 0.18%	3,337 $896,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $65,930 - $80,358	292 Added 9.61%	3,331 $805,000
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $8,978 - $10,126	40 Added 1.33%	3,039 $685,000
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $461 - $513	2 Added 0.07%	2,999 $730,000
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $24,558 - $27,167	112 Added 3.88%	2,997 $725,000
Q4 2021 Jan 20, 2022	SELL	$198.88 - $227.6 $5,568 - $6,372	-28 Reduced 0.96%	2,885 $649,000
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $27,595 - $32,331	130 Added 4.67%	2,913 $619,000
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $26,160 - $29,023	-112 Reduced 3.87%	2,783 $678,000
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $8,876 - $10,344	40 Added 1.4%	2,895 $720,000
Q4 2020 Jan 14, 2021	BUY	$216.38 - $257.67 $38,732 - $46,122	179 Added 6.69%	2,855 $656,000
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $28,158 - $31,314	120 Added 4.69%	2,676 $680,000
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $28,429 - $37,705	156 Added 6.5%	2,556 $518,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $44,464 - $57,152	235 Added 10.85%	2,400 $579,000
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $145,555 - $174,406	836 Added 62.9%	2,165 $419,000
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $13,336 - $15,632	80 Added 6.41%	1,329 $245,000
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $225,906 - $254,646	1,249 New	1,249 $237,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.

Account

Bellecapital International Ltd. Amgen Inc Transaction History